Coronary heart disease risk reduction in postmenopausal women: the role of statin therapy and hormone replacement therapy.

Preventive cardiology

Volumn 7, Issue 3, 2004, Pages 131-136

  Clearfield, Michael ^a  

^a University of North Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CORONARY ARTERY ATHEROSCLEROSIS; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PREVALENCE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CORONARY ARTERIOSCLEROSIS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 7444269488     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2004.3313.x     Document Type: Review

References (47)